TABLE 2.

MICs of Candida strains to AMB and other antifungal agents^a

Characteristic	MICs (mg/L)
	Patient
	1			2					3				4
Isolation site	Oral	Vagina	Oral	Oral	Eso	Toe	Oral	Fingernail	Oral	Oral	Eso	Eso	Oral	Oral
Isolated species	Ca	Ca	Ca	Ca	Ca	Ca	Ca	Ch	Ca	Cg	Ca	Cg	Ca	Ca
Time of analysis	Baseline		On CAMB therapy	Baseline		On CAMB therapy			Baseline		End of CAMB therapy		Baseline	End of CAMB therapy
Antifungal agent
AMB	1	0.25	0.5	1	0.25	0.25	0.25	4	0.5	0.25	0.5	1	0.5	0.5
Anidulafungin	0.5	0.03	0.5	<0.015	<0.015	<0.015	<0.015	0.12	0.03	<0.015	0.015	0.03	<0.015	0.03
Caspofungin	2	0.12	2	0.03	0.06	0.03	0.015	0.25	0.03	0.06	0.015	0.03	0.12	0.03
Micafungin	0.5	0.06	1	0.015	0.015	0.015	0.015	0.25	<0.008	0.015	<0.008	0.015	0.015	0.03
Fluconazole	128	256	128	32	16	64	32	128	8	64	8	32	64	32
Posaconazole	2	8	>8	2	1	8	2	1	0.25	2	0.25	2	>8	2
Voriconazole	2	4	4	1	2	1	1	1	0.12	2	0.12	0.5	2	1

^aMIC, minimum inhibitory concentration; AMB, amphotericin B; CAMB, cochleated amphotericin B; Ca, Candida albicans; Ch, Candida haemulonii; Cg, Candida glabrata; Eso, esophagus.